| Literature DB >> 26795242 |
Françoise Cottrez1, Elodie Boitel1, Jean-Claude Ourlin2, Jean-Luc Peiffer2, Isabelle Fabre2, Imène-Sarah Henaoui3, Bernard Mari3, Ambre Vallauri3, Agnes Paquet3, Pascal Barbry3, Claude Auriault1, Pierre Aeby4, Hervé Groux5.
Abstract
The SENS-IS test protocol for the in vitro detection of sensitizers is based on a reconstructed human skin model (Episkin) as the test system and on the analysis of the expression of a large panel of genes. Its excellent performance was initially demonstrated with a limited set of test chemicals. Further studies (described here) were organized to confirm these preliminary results and to obtain a detailed statistical analysis of the predictive capacity of the assay. A ring-study was thus organized and performed within three laboratories, using a test set of 19 blind coded chemicals. Data analysis indicated that the assay is robust, easily transferable and offers high predictivity and excellent within- and between-laboratories reproducibility. To further evaluate the predictivity of the test protocol according to Cooper statistics a comprehensive test set of 150 chemicals was then analyzed. Again, data analysis confirmed the excellent capacity of the SENS-IS assay for predicting both hazard and potency characteristics, confirming that this assay should be considered as a serious alternative to the available in vivo sensitization tests.Entities:
Keywords: Alternatives to animal tests; Reconstituted epidermis; SENS-IS; Skin sensitization; Toxicogenomics
Mesh:
Substances:
Year: 2016 PMID: 26795242 DOI: 10.1016/j.tiv.2016.01.007
Source DB: PubMed Journal: Toxicol In Vitro ISSN: 0887-2333 Impact factor: 3.500